Systems and methods for prostate treatment

US12544121B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12544121-B2
Application numberUS-202117208329-A
CountryUS
Kind codeB2
Filing dateMar 22, 2021
Priority dateSep 13, 2011
Publication dateFeb 10, 2026
Grant dateFeb 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the vapor delivery needle can be advanced a predetermined distance into the prostate by an actuation mechanism. The actuation mechanism can comprise, for example, a spring, or at least one magnet. Methods associated with use of the energy delivery probe are also covered.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of treating prostate tissue, comprising: inserting a shaft of a prostate therapy device transurethrally until a working end of the shaft is proximate to the prostate tissue of a patient; actuating a magnetic assembly to advance a vapor delivery needle from a retracted position located within the shaft to an extended position radially outwardly of the shaft and into the prostate tissue, wherein the magnetic assembly includes a first magnetic member that is coupled to the vapor delivery needle such that the first magnetic member moves with the vapor delivery needle as the vapor delivery needle is advanced, wherein the magnetic assembly includes a second magnetic member configured to exert a force on the first magnetic member to advance the vapor delivery needle, and wherein the first magnetic member and the second magnetic member are disposed within a handle of the prostate therapy device, and wherein the second magnetic member remains proximal to the first magnetic member before and after the vapor delivery needle is advanced; releasing a lock to permit delivery of condensable vapor to tissue of the patient when the vapor delivery needle is in the extended position; delivering condensable vapor from the vapor delivery needle into the prostate tissue to provide a thermal effect in a first region of the prostate tissue; and delivering condensable vapor from the vapor delivery needle into the prostate tissue to provide a thermal effect in a second region of the prostate tissue; wherein the first region and the second region partially overlap. 2 . The method of claim 1 , further including: before delivering condensable vapor from the vapor delivery needle into the prostate tissue to provide a thermal effect in the second region of the prostate tissue, moving the vapor delivery needle from the extended position to the retracted position; moving the working end of the shaft to an second location proximate to the prostate tissue of the patient; and actuating the magnetic assembly to advance the vapor delivery needle from a retracted position to the extended position. 3 . The method of claim 1 , wherein actuating the magnetic assembly includes causing magnetic attraction between a first set of components of the magnetic assembly in the handle of the prostate therapy device to drive the vapor delivery needle distally a first distance and causing magnetic repulsion between a second set of components of the magnetic assembly to drive the vapor delivery needle distally a second distance. 4 . The method of claim 1 , further including: before actuating the magnetic assembly to advance the vapor delivery needle from the retracted position to the extended position, selecting a predetermined distance, and wherein actuating the magnetic assembly to advance the vapor delivery needle from the retracted position to the extended position causes the vapor delivery needle to move the predetermined distance. 5 . The method of claim 1 , further comprising: dampening a force of actuation of the vapor delivery needle by contacting a flange with at least one bumper element at an end of a stroke of the vapor delivery needle, wherein the at least one bumper element includes a spring. 6 . A method of treating prostate tissue, comprising: inserting a shaft of a prostate therapy device transurethrally until a working end of the shaft is proximate to the prostate tissue; actuating a magnetic assembly within a handle of the prostate therapy device, in order to advance a vapor delivery needle from a retracted position located within the shaft to an extended position radially outwardly of the shaft and into the prostate tissue, wherein the magnetic assembly includes a plurality of first magnets disposed in a block that is fixedly coupled to the vapor delivery needle, and wherein the magnetic assembly includes a plurality of second magnets configured to deliver a force to the plurality of first magnets to advance the vapor delivery needle, wherein the plurality of second magnets is configured to rotate around a longitudinal axis of the shaft; delivering condensable vapor from the vapor delivery needle into the prostate tissue to provide a thermal effect in a first region of the prostate tissue; and delivering condensable vapor from the vapor delivery needle into the prostate tissue to provide a thermal effect in a second region of the prostate tissue; wherein the first region and the second region partially overlap. 7 . The method of claim 6 , further including: irrigating a urethra with a cooling fluid during delivery of the condensable vapor. 8 . The method of claim 6 , wherein actuating the magnetic assembly includes causing magnetic repulsion between at least one magnet of the plurality of first magnets and at least one magnet of the plurality of second magnets, such that at least one of the first plurality of magnets is moved relative to the second plurality of magnets to move the vapor delivery needle. 9 . The method of claim 6 , wherein an interlock mechanism of the handle of the prostate therapy device permits actuation of vapor flow only if a releasable lock has been released. 10 . The method of claim 6 , wherein actuating the magnetic assembly includes causing magnetic attraction between a plurality of third magnets and the plurality of first magnets to drive the vapor delivery needle distally a first distance and causing magnetic repulsion between the plurality of second magnets and the plurality of first magnets to drive the vapor delivery needle distally a second distance. 11 . A method of treating prostate tissue, comprising: inserting a shaft of a prostate therapy device sized and configured for transurethral access into a patient; actuating a magnetic assembly to advance a vapor delivery needle from a retracted position in the shaft to an extended position radially outward of the shaft and into the prostate tissue, wherein the magnetic assembly includes at least a first member and a second member within a handle of the prostate therapy device, and wherein actuating the magnetic assembly includes causing at least one of the first member or the second member to move relative to the other of the first member or the second member, wherein the first member is coupled to the vapor delivery needle and configured to move distally relative to the shaft, wherein the second member is configured to rotate relative to the first member so as to apply a magnetic force to the first member and advance the vapor delivery needle; and releasing a lock to permit delivery of condensable vapor to tissue of the patient when the vapor delivery needle is in the extended position. 12 . The method of claim 11 , wherein causing at least one of the first member or the second member to move relative to the other of the first member or the second member includes causing at least one of the first member or the second member to rotate relative to the other of the first member or the second member. 13 . The method of claim 11 , wherein the magnetic assembly further includes a third member configured to rotate relative to the first member, wherein a rotation of the second member and the third member relative to the first member applies a force upon the first member in order to move the vapor delivery needle distally or proximally between the second member and the third member. 14 . The method of claim 11 , wherein the magnetic force causes the vapor delivery needle to move toward the extended position from the retracted position at a velocity ranging from 0.1 meters per second to 20.0 meters per second.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12544121B2 cover?
A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the vapor delivery needle can be advanced a predetermined distance into the prostate by an actuation mechanism. The actuation mecha…
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1492. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).